Nanomedicine · Nov 19, 2026

Remote nanomagnetic activation of mechanotransduction: principles, therapeutic applications, and translational challenges

By Du Y, Broomhall T, Rotherham M et al.

Mechanical signaling is increasingly recognized as a therapeutic target and a key element of the stem cell niche in regenerative medicine and disease. Magnetic nanoparticles (MNPs) offer a practical route for delivering such cues because they can be actuated remotely, functionalized with ligands and incorporated into cells, scaffolds, hydrogels or assay platforms. Magnetically driven mechanotransduction provides evidence that MNPs can act not only as carriers, labels or heating agents, but as active interfaces controlling cell signaling and fate. This review places magnetic ion channel activation (MICA) within magnetic nanomedicine, including magnetic resonance imaging, targeted drug delivery, hyperthermia and magnetic biomaterials. Magneto-mechanical stimulation adds design variables including force, torque, surface functionalisation, target access and particle behavior at the biointerface. Particular attention is given to mechanosensitive targets, including TREK1, TRPV4, PIEZO1, integrins and Frizzled/Wnt signaling. Applications are graded by preclinical maturity: bone repair is best developed, followed by peripheral nerve, cartilage, immune and biofabrication work. A central theme is the evidence pipeline connecting acute cell-level signaling with tissue-level outcomes. Translational barriers include particle quality control, aggregation and protein-corona effects, internalization, field dosimetry, degradation, specificity and uneven reporting. A healthcare future will depend on standardized benchmark models, biogenic MNPs and long-term in vivo outcome data.

doi.org/10.1080/17435889.2026.2760493Open accessPubMed 43053697Interventions

AgingResearch.News